Alamandine reduces eosinophilic inflammation in an experimental model of asthma

J. Gregório (Belo Horizonte, Brazil), G. Magalhães (Belo Horizonte, Brazil), G. Rodrigues-Machado (Belo Horizonte, Brazil), K. Gonzaga (Belo Horizonte, Brazil), A. Oliveira (Belo Horizonte, Brazil), F. Souza-Neto (Belo Horizonte, Brazil), B. Rezende (Belo Horizonte, Brazil), V. Pinho (Belo Horizonte, Brazil), L. Barcelos (Belo Horizonte, Brazil), R. Da Silva (Belo Horizonte, Brazil), R. Santos (Belo Horizonte, Brazil), M. Campagnole-Santos (Belo Horizonte, Brazil)

Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Session: Novel immunology-based therapies in asthma and COPD
Session type: Oral Presentation
Number: 1648
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Gregório (Belo Horizonte, Brazil), G. Magalhães (Belo Horizonte, Brazil), G. Rodrigues-Machado (Belo Horizonte, Brazil), K. Gonzaga (Belo Horizonte, Brazil), A. Oliveira (Belo Horizonte, Brazil), F. Souza-Neto (Belo Horizonte, Brazil), B. Rezende (Belo Horizonte, Brazil), V. Pinho (Belo Horizonte, Brazil), L. Barcelos (Belo Horizonte, Brazil), R. Da Silva (Belo Horizonte, Brazil), R. Santos (Belo Horizonte, Brazil), M. Campagnole-Santos (Belo Horizonte, Brazil). Alamandine reduces eosinophilic inflammation in an experimental model of asthma. 1648

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: